|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| A61K 31/519 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Patento numeris | 2331547 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09782051.8 |
| Europos patento paraiškos padavimo data | 2009-08-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-06-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-07-30 |
| (46) | Apibrėžties vertimo paskelbimo data | 2014-11-25 |
| (86) | Numeris | PCT/EP2009/060793 |
| Data | 2009-08-20 |
| (87) | Numeris | WO 2010/020675 |
| Data | 2010-02-25 |
| (30) | Numeris | Data | Šalis |
| 91037 P | 2008-08-22 | US |
| (72) |
BESONG, Gilbert, GB
BRAIN, Christopher Thomas, US
BROOKS, Clinton A., US
CONGREVE, Miles Stuart, GB
DAGOSTIN, Claudio, GB
HE, Guo, US
HOU, Ying, US
HOWARD, Steven, GB
LI, Yue, CN
LU, Yipin, US
MORTENSON, Paul, GB
SMITH, Troy, US
SUNG, Moo, US
WOODHEAD, Steven, GB
WRONA, Wojciech, US
LAGU, Bharat, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
Astex Therapeutics Ltd., 436 Cambridge Science Park Milton Road, Cambridge CB4 0QA, GB |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Pirolopirimidino junginiai, kaip CDK inhibitoriai |
| PYRROLOPYRIMIDINE COMPOUNDS AS CDK INHIBITORS |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2025-07-23 | 17 | 347.00 EUR |
| 2026-08-20 |